Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Birabresib

🥰Excellent
Catalog No. T6032Cas No. 202590-98-5
Alias OTX015 (MK 8628/Birabresib), OTX-015, MK-8628

Birabresib (MK-8628) is a synthetic, small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins 2, 3 and 4 with potential antineoplastic activity.

Birabresib

Birabresib

🥰Excellent
Purity: 99.93%
Catalog No. T6032Alias OTX015 (MK 8628/Birabresib), OTX-015, MK-8628Cas No. 202590-98-5
Birabresib (MK-8628) is a synthetic, small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins 2, 3 and 4 with potential antineoplastic activity.
Pack SizePriceAvailabilityQuantity
2 mg$41In Stock
5 mg$67In Stock
10 mg$87In Stock
25 mg$153In Stock
50 mg$247In Stock
100 mg$417In Stock
200 mg$622In Stock
500 mg$992In Stock
1 mL x 10 mM (in DMSO)$72In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Birabresib"

Select Batch
Purity:99.93%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Birabresib (MK-8628) is a synthetic, small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins 2, 3 and 4 with potential antineoplastic activity.
Targets&IC50
BRDs:10-19 nM(EC50)
In vitro
Birabresib inhibits the binding of BRD2, BRD3, and BRD4 to AcH4 with IC50 ranging from 92 to 112 nM, and inhibits the growth of a variety of human cancer cell lines with GI50 ranging from 60 to 200 nM. [1] Birabresib results in rapid down-regulation of c-MYC expression, and show the synergistic anti-proliferative effects in combination with ALK inhibitors in ALKpos ALCL cell lines. [2]
In vivo
OTX015 (p.o.) significantly inhibits the growth of Ty82 BRD-NUT midline carcinoma tumors in nude mice by 79% at 100 mg/kg qd and 61% at 10 mg/kg bid, respectively. [1]
Kinase Assay
Cell Research
Effects of OTX015 on cancer cell proliferation are evaluated by incubating human tumor cells for 72 h with increasing concentrations of OTX015 and assessing proliferation using a tetrazolium salt (WST-8)-based colorimetric assay.(Only for Reference)
AliasOTX015 (MK 8628/Birabresib), OTX-015, MK-8628
Chemical Properties
Molecular Weight491.99
FormulaC25H22ClN5O2S
Cas No.202590-98-5
SmilesCC=1C2=C(N3C([C@H](CC(NC4=CC=C(O)C=C4)=O)N=C2C5=CC=C(Cl)C=C5)=NN=C3C)SC1C
Relative Density.1.45 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
Ethanol: 9.8 mg/mL (20 mM)
DMSO: 45 mg/mL (91.47 mM), Sonication is recommended.
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM2.0326 mL10.1628 mL20.3256 mL101.6281 mL
5 mM0.4065 mL2.0326 mL4.0651 mL20.3256 mL
10 mM0.2033 mL1.0163 mL2.0326 mL10.1628 mL
20 mM0.1016 mL0.5081 mL1.0163 mL5.0814 mL
DMSO
1mg5mg10mg50mg
50 mM0.0407 mL0.2033 mL0.4065 mL2.0326 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Birabresib | purchase Birabresib | Birabresib cost | order Birabresib | Birabresib chemical structure | Birabresib in vivo | Birabresib in vitro | Birabresib formula | Birabresib molecular weight